Close Menu
Global News HQ
    What's Hot

    Before You Buy the XRP Dip, Watch for This Key Trigger (Analyst)

    July 29, 2025

    Cincinnati EPS Jumps 53 Percent in Q2 | The Motley Fool

    July 29, 2025

    What Is a Training and Development Certificate?

    July 29, 2025
    Recent Posts
    • Before You Buy the XRP Dip, Watch for This Key Trigger (Analyst)
    • Cincinnati EPS Jumps 53 Percent in Q2 | The Motley Fool
    • What Is a Training and Development Certificate?
    • Why Jesse McBee Was Hesitant To Ask Alli for a Prenup With “$50M Payout” at Stake (EXCLUSIVE) | Bravo
    • Bitcoin Rejected At $120,000: Binance Whale Inflows Suggest Possible Drop To $110,000
    Facebook X (Twitter) Instagram YouTube TikTok
    Trending
    • Before You Buy the XRP Dip, Watch for This Key Trigger (Analyst)
    • Cincinnati EPS Jumps 53 Percent in Q2 | The Motley Fool
    • What Is a Training and Development Certificate?
    • Why Jesse McBee Was Hesitant To Ask Alli for a Prenup With “$50M Payout” at Stake (EXCLUSIVE) | Bravo
    • Bitcoin Rejected At $120,000: Binance Whale Inflows Suggest Possible Drop To $110,000
    • I Swear By the $10 Pain Relief Gel Shoppers Say Makes Aches and Soreness ‘Disappear’
    • The first company to complete a fully successful lunar landing is going public
    • We Swept Up 3 Weeks’ Worth of Debris to Find the 7 Best Brooms 
    Global News HQ
    • Technology & Gadgets
    • Travel & Tourism (Luxury)
    • Health & Wellness (Specialized)
    • Home Improvement & Remodeling
    • Luxury Goods & Services
    • Home
    • Finance & Investment
    • Insurance
    • Legal
    • Real Estate
    • More
      • Cryptocurrency & Blockchain
      • E-commerce & Retail
      • Business & Entrepreneurship
      • Automotive (Car Deals & Maintenance)
    Global News HQ
    Home - Technology & Gadgets - Seasonal COVID shots may no longer be possible under Trump admin
    Technology & Gadgets

    Seasonal COVID shots may no longer be possible under Trump admin

    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Seasonal COVID shots may no longer be possible under Trump admin
    Share
    Facebook Twitter LinkedIn Pinterest Email



    Under President Trump, the Food and Drug Administration may no longer approve seasonal COVID-19 vaccines updated for the virus variants circulating that year, according to recent statements by Trump administration officials.

    Since the acute phase of the pandemic, vaccine manufacturers have been subtly updating COVID-19 shots annually to precisely target the molecular signatures of the newest virus variants, which continually evolve to evade our immune responses. So far, the FDA has treated these tweaked vaccines the same way it treats seasonal flu shots, which have long been updated annually to match currently circulating strains of flu viruses.

    The FDA does not consider seasonal flu shots brand-new vaccines. Rather, they’re just slightly altered versions of the approved vaccines. As such, the regulator does not require companies to conduct lengthy, expensive vaccine trials to prove that each slightly changed version is safe and effective. If they did, generating annual vaccines would be virtually impossible. Each year, from late February to early March, the FDA, the Centers for Disease Control and Prevention, and the World Health Organization direct flu shot makers on what tweaks they should make to shots for the upcoming flu season. That gives manufacturers just enough time to develop tweaks and start manufacturing massive supplies of doses in time for the start of the flu season.

    So far, COVID-19 vaccines have been treated the exact same way, save for the fact that the vaccines that use mRNA technology do not need as much lead time for manufacturing. In recent years, the FDA decided on formulations for annual COVID shots around June, with doses rolled out in the fall alongside flu shots.

    However, this process is now in question based on statements from Trump administration officials. The statements come amid a delay in a decision on whether to approve the COVID-19 vaccine made by Novavax, which uses a protein-based technology, not mRNA. The FDA was supposed to decide whether to grant the vaccine full approval by April 1. To this point, the vaccine has been used under an emergency use authorization by the agency.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleNike May Be Facing a $5 Million Lawsuit for Shuttering Its NFT Platform
    Next Article Ohio Will Allow Employers to Electronically Post Certain Workplace Labor and Employment Notices

    Related Posts

    The first company to complete a fully successful lunar landing is going public

    July 29, 2025

    Whistle pet trackers are shutting down next month

    July 29, 2025

    iOS 18 vs. iOS 26: Here's What Liquid Glass Brings to Your iPhone

    July 28, 2025

    Yes, you can store data on a bird — enthusiast converts PNG to bird-shaped waveform, teaches young starling to recall file at up to 2MB/s

    July 28, 2025
    Leave A Reply Cancel Reply

    ads
    Don't Miss
    Cryptocurrency & Blockchain
    2 Mins Read

    Before You Buy the XRP Dip, Watch for This Key Trigger (Analyst)

    TL;DR After skyrocketing past its old all-time high at $3.4 about ten days ago, Ripple’s…

    Cincinnati EPS Jumps 53 Percent in Q2 | The Motley Fool

    July 29, 2025

    What Is a Training and Development Certificate?

    July 29, 2025

    Why Jesse McBee Was Hesitant To Ask Alli for a Prenup With “$50M Payout” at Stake (EXCLUSIVE) | Bravo

    July 29, 2025
    Top
    Cryptocurrency & Blockchain
    2 Mins Read

    Before You Buy the XRP Dip, Watch for This Key Trigger (Analyst)

    TL;DR After skyrocketing past its old all-time high at $3.4 about ten days ago, Ripple’s…

    Cincinnati EPS Jumps 53 Percent in Q2 | The Motley Fool

    July 29, 2025

    What Is a Training and Development Certificate?

    July 29, 2025
    Our Picks
    Cryptocurrency & Blockchain
    2 Mins Read

    Before You Buy the XRP Dip, Watch for This Key Trigger (Analyst)

    TL;DR After skyrocketing past its old all-time high at $3.4 about ten days ago, Ripple’s…

    Finance & Investment
    5 Mins Read

    Cincinnati EPS Jumps 53 Percent in Q2 | The Motley Fool

    Cincinnati Financial (CINF -1.54%), an insurance company specializing in property, casualty, and life insurance, reported…

    Pages
    • About Us
    • Contact Us
    • Disclaimer
    • Homepage
    • Privacy Policy
    Facebook X (Twitter) Instagram YouTube TikTok
    • Home
    © 2025 Global News HQ .

    Type above and press Enter to search. Press Esc to cancel.

    Go to mobile version